Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

BTAIBTAI
Showing 8 of 29 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in BIOXCEL THERAPEUTICS INC

BNP PARIBAS FINANCIAL MARKETS holds 12 shares of BTAI (BIOXCEL THERAPEUTICS INC), worth $17 as of 2026-Q2. The position was decreased (-79.7% shares).

Current Value

$17

Current Shares

12

Total Value Change

-$27,055

Total Shares Change

-44,369

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
12
-79.7%
$170.0%$1.41
0
2026-Q1
Increased
59
+391.7%
$790.0%$1.60
12
2025-Q4
Decreased
12
-69.2%
$190.0%$1.53
0
2025-Q3
Decreased
39
-11.4%
$1000.0%$2.62
0
2025-Q2
Unchanged
44
0.0%
$800.0%$1.77
0
2025-Q1
Decreased
44
-98.1%
$890.0%$2.12
0
2024-Q4
Decreased
2,321
-94.8%
$8680.0%$5.87
0
2024-Q3
Decreased
44,381
-83.8%
$27,0720.0%$9.65
0

Other major holders of BTAI: ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC, ALLIANCEBERNSTEIN L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used